???global.info.a_carregar???
Carolina Silva-Pereira (CSP) completed the Integrated Master's in Pharmaceutical Sciences at Faculty of Pharmacy of University of Porto (FFUP), and is currently finalizing her Ph.D. in Experimental and Clinical Pharmacology and Toxicology from the Faculty of Medicine of University of Porto (FMUP). Her research focuses on inflammation resolution pathways in hospitalized COVID-19 patients, while also contributing to various research projects over the years. Since 2019, she has primarily worked in clinical research, investigating biomarkers of inflammation, resolution of inflammation, endothelial dysfunction and oxidative stress in patients with acute heart failure, cardiogenic shock, septic shock and COVID-19. This work has led to four original research articles and one review. CSP has actively participated in national and international conferences, presenting her findings through oral communications and posters. She is a student member of the Portuguese Society of Pharmacology, and she recently became an Invited Assistant of Pharmacology at FMUP.
Read full resume ↓
Identification

Personal identification

Full name
Carolina Isabel Ribeiro da Silva Pereira

Citation names

  • Silva-Pereira, Carolina

Author identifiers

Ciência ID
8D1C-1983-965D
ORCID iD
0000-0001-7805-930X

Knowledge fields

  • Ciências Médicas e da Saúde - Medicina Clínica - Sistemas Cardíacos e Cardiovasculares
  • Ciências Médicas e da Saúde - Medicina Básica - Farmacologia e Farmácia

Languages

Language Speaking Reading Writing Listening Peer-review
Português (Mother tongue)
Inglês
Espanhol; Castelhano
Education
Degree Classification
2024/06/11 - 2024/06/21
Concluído
 Laboratory Animal Sciences Course – Modular Structure (rodents) (Diploma de especialização)
Universidade do Porto Faculdade de Medicina, Portugal
2019/12 - 2024
Em curso
 Doctoral Programme in Experimental and Clinical Pharmacology and Toxicology (Doutoramento)
Universidade do Porto Faculdade de Medicina, Portugal
2012/09 - 2018/04
Concluído
 Mestrado Integrado em Ciências Farmacêuticas (Mestrado integrado)
Universidade do Porto Faculdade de Farmácia, Portugal
 16
Affiliation

Ciência

Category
Host institution 		Employer
2019/03 - Current Investigador (Investigação) Universidade do Porto Faculdade de Medicina, Portugal
Departamento de Biomedicina - Unidade de Farmacologia e Terapêutica, Faculdade de Medicina da Universidade do Porto, Portugal

Docência no Ensino Superior

Category
Host institution 		Employer
2024/09/01 - Current Assistente Convidado (Docente Universitário) Universidade do Porto Faculdade de Medicina, Portugal

Outros

Category
Host institution 		Employer
2019/01 - 2019/02 Hospital Pharmacy Volunteering Hospital do Mal de Hansen, Guiné-Bissau
2018/04 - 2018/08 Erasmus+ Internship University of Exeter, Reino Unido
2017/11 - 2018/02 Curricular Intership Farmácia Vitória, Portugal
Universidade do Porto Faculdade de Farmácia, Portugal
2017/09 - 2017/10 Curricular Intership Hospital Privado de Braga, Portugal
Universidade do Porto Faculdade de Farmácia, Portugal
2015/07 - 2015/07 Extracurricular Internship Farmácia Dias Machado, Portugal
Associação de Estudantes da Faculdade de Farmácia da Universidade do Porto, Portugal
2014/07 - 2014/08 Extracurricular Internship Farmácia Mariedeira, Portugal
Associação Portuguesa de Estudantes de Farmácia, Portugal
Projects

Projeto

Designation Funders
2019/03/01 - 2022/07 Resolution of inflammation: a missing key to improve acute heart failure treatment and prognosis?
PTDC/MEC-CAR/32188/2017
POCI-01-0145-FEDER-032188
Investigador
Universidade do Porto, Portugal
 Fundação para a Ciência e a Tecnologia

European Regional Development Fund
Em curso
2020/07/09 - 2021/07/08 Unresolved inflammation and endothelitis in severe COVID-19 patients: identification of risk stratification biomarkers and therapeutic targets
613690173
Investigador
Universidade do Porto Faculdade de Medicina, Portugal
 Fundação para a Ciência e a Tecnologia
Concluído
Outputs

Publicações

Artigo em revista
  1. Reina-Couto, Marta; Alves, David; Silva-Pereira, Carolina; Pereira-Terra, Patrícia; Martins, Sandra; Bessa, João; Teixeira-Santos, Luísa; et al. "Endocan as a marker of endotheliitis in COVID-19 patients: modulation by veno-venous extracorporeal membrane oxygenation, arterial hypertension and previous treatment with renin–angiotensin–aldosterone system inhibitors". Inflammation Research 74 1 (2025): https://doi.org/10.1007/s00011-024-01964-8.
    10.1007/s00011-024-01964-8
  2. Reina-Couto, Marta; Roboredo-Madeira, Mariana; Pereira-Terra, Patrícia; Silva-Pereira, Carolina; Martins, Sandra; Teixeira-Santos, Luísa; Pinho, Dora; et al. "Evaluation of urinary cysteinyl leukotrienes as biomarkers of severity and putative therapeutic targets in COVID-19 patients". Inflammation Research 72 3 (2023): 475-491. http://dx.doi.org/10.1007/s00011-022-01682-z.
    Publicado • 10.1007/s00011-022-01682-z
  3. Reina-Couto, Marta; Santos-Oliveira, Marisa; Pereira-Terra, Patrícia; Silva-Pereira, Carolina; Quelhas-Santos, Janete; Duarte, Álvaro; Martins, Sandra; et al. "Urinary Cysteinyl Leukotrienes as Biomarkers of Endothelial Activation, Inflammation and Oxidative Stress and Their Relationship with Organ Dysfunction in Human Septic Shock". Biomedicines 10 11 (2022): 2845. http://dx.doi.org/10.3390/biomedicines10112845.
    Publicado • 10.3390/biomedicines10112845
  4. Reina-Couto, Marta; Silva-Pereira, Carolina; Pereira-Terra, Patrícia; Quelhas-Santos, Janete; Bessa, João; Serrão, Paula; Afonso, Joana; et al. "Endothelitis profile in acute heart failure and cardiogenic shock patients: Endocan as a potential novel biomarker and putative therapeutic target". Frontiers in Physiology 13 (2022): http://dx.doi.org/10.3389/fphys.2022.965611.
    Publicado • 10.3389/fphys.2022.965611
  5. Reina-Couto, Marta; Pereira-Terra, Patrícia; Quelhas-Santos, Janete; Silva-Pereira, Carolina; Albino-Teixeira, António; Sousa, Teresa. "Inflammation in Human Heart Failure: Major Mediators and Therapeutic Targets". Frontiers in Physiology 12:746494 (2021): http://dx.doi.org/10.3389/fphys.2021.746494..
    Publicado • 10.3389/fphys.2021.746494
Poster em conferência
  1. Silva-Pereira, Carolina; Reina-Couto, M.; Teixeira-Santos, Luísa; Pereira-Terra, Patrícia; Martins, Sandra; Pinho, Dora; Soares, Miguel Luz ; et al. "Resolvin E1, an omega-3-derived proresolving lipid mediator, best distinguishes COVID-19 severity among a panel of inflammatory cytokines and proresolution markers". Paper presented in Encontro Ciência 2024 – Encontro com a Ciência e a Tecnologia em Portugal, 2024.
  2. Reina-Couto, Marta; Pereira-Terra, Patricia; Silva-Pereira, Carolina; Quelhas-Santos, Janete; Martins, Sandra; Teixeira-Santos, Luísa; Pinho, Dora; et al. "The lipoxin receptor FPR2/ALX is associated with lower inflammation and better prognosis in human acute heart failure". Paper presented in 9th European Workshop on Lipid Mediators, 2024.
  3. Silva-Pereira, Carolina; Reina-Couto, Marta; Teixeira-Santos, Luísa; Pereira-Terra, Patricia; Martins, Sandra; Pinho, Dora; Soares, Miguel Luz ; et al. "Dysregulation of Resolvin E1-Chemerin1 axis in critical COVID-19 patients". Paper presented in 9th European Workshop on Lipid Mediators, 2024.
  4. Teixeira-Santos, Luísa; Pinho, Dora; Reina-Couto, Marta; Silva-Pereira, Carolina; Pereira-Terra, Patrícia; Dias, Andreia; Cordeiro, Gonçalo; et al. "Increased urinary isoprostanes are associated with severity and mortality in COVID-19 patients [ID:505]". Paper presented in 8th European Virtual Congress of Pharmacology (EPHAR 2021), 2021.
  5. Ferreira-Duarte, Mariana; Reina-Couto, Marta; Silva-Pereira, Carolina; Pereira-Terra, Patrícia; Teixeira-Santos, Luísa; Pinho, Dora; Madeira, Mariana; et al. "Angiotensin-converting enzyme 2 (ACE2) activity in COVID-19 patients: a study throughout hospitalization in different stages of disease severity [ID:514]". Paper presented in 8th European Virtual Congress of Pharmacology (EPHAR 2021), 2021.
  6. Duarte A; Reina-Couto, M.; Silva-Pereira, Carolina; Pereira-Terra, Patricia; Quelhas-Santos Janete; Santos-Oliveira, M.; Martins, Sandra; et al. "Angiotensinogen and hydrogen peroxide in acute heart failure and cardiogenic shock and their association with endothelial activation, inflammation and oxidative stress". Paper presented in 16th YES Meeting, Porto, Portugal, 2021.
  7. Sousa-Oliveira, Ana; Reina-Couto, M.; Oliveira-Santos, Marisa; Silva-Pereira, Carolina; Pereira-Terra, Patricia; Quelhas-Santos Janete; Serrão, Paula; et al. "Balance between proinflammatory and proresolving eicosanoids in patients with acute heart failure and cardiogenic shock". Paper presented in 16th YES Meeting, Porto, Portugal, 2021.
Resumo em conferência
  1. Reina-Couto, M.; Pereira-Terra, Patricia; Silva-Pereira, Carolina; Quelhas-Santos Janete; Martins, Sandra; Teixeira-Santos, Luísa; Pinho, Dora; et al. Autor correspondente: Reina-Couto, M.. "Lipoxins receptor is associated with prognosis and endothelitis in icu patients with acute heart failure but not in those with cardiogenic shock. Intensive Care Medicine Experimental 2023, 11 (Suppl 1): 001280". Paper presented in 36th Annual Congress of the European Society of Intensive Care Medicine, ESICM Lives 2023, Milan, 2023.
    Publicado
  2. Silva-Pereira, Carolina; Reina-Couto, M.; Alves D; Pereira-Terra, Patricia; Martins S; Bessa J; Teixeira-Santos, Luísa; et al. "Proinflammatory and endothelial activation profiles in hospitalized COVID-19 patients: impact of arterial hypertension and previous treatment with renin-angiotensin-aldosterone inhibitors.. Br J Pharmacol 2023; 180(S1):198-199 [P0895]". Paper presented in 19th World Congress of Basic & Clinical Pharmacology 2023 (WCP2023), Glasgow, 2023.
    Publicado
  3. Reina-Couto, M.; Pereira-Terra, Patricia; Silva-Pereira, Carolina; Quelhas-Santos Janete; Martins S; Teixeira-Santos, Luísa; Pinho, Dora; et al. "Lipoxins profile and FPR2/ALX receptor expression in human acute heart failure and cardiogenic shock. Br J Pharmacol 2023; 180(S1):813-814 [P1023]". Paper presented in 19th World Congress of Basic & Clinical Pharmacology 2023 (WCP2023), Glasgow, 2023.
    Publicado
  4. Reina-Couto, M.; Silva-Pereira, Carolina; Pereira-Terra, Patricia; Quelhas-Santos Janete; Martins S; Teixeira-Santos, Luísa; Pinho, Dora; et al. "Inflammatory versus resolutive responses and endothelial dysfunction in critically ill patients: differences in cardiogenic shock, septic shock and critical COVID-19 profiles. Intensive Care Med Exp 2022; 10(Suppl 2):39 [001434] doi:10.1186/s40635-022-00468-1". Paper presented in 35th Annual Congress of the European Society of Intensive Care Medicine, ESICM Lives 2022, Paris, 2022.
    Publicado
  5. Reina-Couto, Marta; Pereira-Terra, Patrícia; Silva-Pereira, Carolina; Quelhas-Santos, Janete; Serrão, Paula; Afonso, Joana; Martins, Sandra; et al. "Venoarterial extracorporeal membrane oxygenation appears to induce higher neutrophil-derived inflammation and oxidative stress at the end of the first week of hospitalization. Intensive Care Medicine Experimental. 9 (Suppl 1): 51.". Paper presented in 34th Annual Congress of the European Society of Intensive Care Medicine, ESICM LIVES DIGITAL 2021, 2021.
    Publicado • 10.1186/s40635-021-00413-8
  6. Reina-Couto, Marta; Silva-Pereira, Carolina; Pereira-Terra, Patrícia; Quelhas-Santos, Janete; Bessa, João; Marques, C; Serrão, Paula; et al. "Endocan - a potential new biomarker of inflammation-driven endothelitis in human acute heart failure and cardiogenic shock. Rev. Port. Cardiol. 40 (Espec Cong):75-76.". Paper presented in Congresso Português de Cardiologia 2021 - Virtual, 2021.
    Publicado
  7. Reina-Couto, Marta; Silva-Pereira, Carolina; Pereira-Terra, Patrícia; Quelhas-Santos, Janete; Pinho, Dora; Martins, Sandra; Serrão, Paula; et al. "Proinflammatory cytokines and endothelial cell activation in human acute heart failure versus septic shock. Intensive Care Medicine Experimental. 8(Suppl 2): 001521.". Paper presented in 33rd Annual Congress of the European Society of Intensive Care Medicine, ESICM LIVES DIGITAL 2020, 2020.
    Publicado • 10.1186/s40635-020-00354-8
  8. Reina-Couto, Marta; Silva-Pereira, Carolina; Quelhas-Santos Janete; Pinho, Dora; Martins, Sandra; Serrão, Paula; Afonso, Joana; et al. "Proinflammatory cytokines and endothelial cell activation in human acute heart failure and cardiogenic shock. European Journal of Clinical Investigation. 50(Suppl. 1):44-45.". Paper presented in European Society for Clinical Investigation (ESCI) Virtual Meeting 2020 | Covid19 edition, 2020.
    Publicado • 10.1111/eci.13369
  9. Silva-Pereira, Carolina; Reina-Couto, Marta; Quelhas-Santos, Janete; Sousa-Oliveira, Ana; Duarte, Álvaro; Pinho, Dora; Serrão, Paula; et al. "Lipoxin profiles in human acute heart failure and cardiogenic shock and their modulation by aspirin or statin therapy. European Journal ofClinical Investigation. 50(Suppl. 1):43.". Paper presented in European Society for Clinical Investigation (ESCI) Virtual Meeting 2020 | Covid19 edition, 2020.
    Publicado • 10.1111/eci.13369.
  10. Reina-Couto, Marta; Silva-Pereira, Carolina; Bessa, João; Oliveira-Santos, Marisa; Serrão, Paula; Afonso, Joana; Roncon-Albuquerque, Roberto; et al. "Inflammation and resolution of inflammation in human acute heart failure. Intensive Care Medicine Experimental. 7(Suppl 3):001499.". Paper presented in 32nd Annual Congress of the European Society of Intensive Care Medicine (ESICM LIVES 2019), Berlin, 2019.
    Publicado • 10.1186/s40635-019-0265-y
Activities

Apresentação oral de trabalho

Presentation title Event name
Host (Event location)
2025/02/06 Interplay between the proresolving mediators Annexin A1 and Resolvin E1 in hospitalized COVID-19 patients 55th Meeting of the Portuguese Society of Pharmacology
Faculdade de Medicina da Universidade do Porto (Porto, Portugal)
2024/12/19 Resolvin E1-Chemerin receptor 1 axis is dysregulated in critical COVID-19 patients 3º Encontro do DBM – Encontro I&D – Programas Doutorais
Faculdade de Medicina da Universidade do Porto (Porto, Portugal)
2024/02 Resolvin E1 is a major mediator of the inflammatory response in hospitalized COVID-19 patients 54th Meeting of the Portuguese Society of Pharmacology
Universidade Nova de Lisboa (Lisboa, Portugal)
2023/09/25 Impact of hypertension and previous treatment with RAAS inhibitors on endotelial dysfunction in hospitalized COVID-19 patients Seminar Renin-Angiotensin-Aldosterone System in Health and Disease - New insights into a classic system
Faculdade de Farmácia da Universidade do Porto (Porto, Portugal)
2023/09/25 Renin-angiotensin-aldosterone system in acute heart failure and cardiogenic shock Seminar Renin-Angiotensin-Aldosterone System in Health and Disease - New insights into a classic system
Faculdade de Farmácia da Universidade do Porto (Porto, Portugal)
2023/09/25 Activity of angiotensin-converting enzymes (ACE and ACE2) in patients with COVID-19 of different severity Seminar “Renin-Angiotensin-Aldosterone System in Health and Disease - New insights into a classic system”
Faculdade de Farmácia da Universidade do Porto (Porto, Portugal)
2023/09 Endothelial dysfunction in different stages of disease severity of COVID-19: focus on endocan and arterial hypertension 18th YES Meeting
Faculdade de Medicina da Universidade do Porto (Porto, Portugal)
2023/02/01 Endothelial dysfunction in different stages of covid-19 severity LIII Reunião da Sociedade Portuguesa de Farmacologia (SPF 2023)
Sociedade Portuguesa de Farmacologia (Coimbra, Portugal)
2023/02/01 Evaluation of urinary cysteinyl leukotrienes as biomarkers of severity and putative therapeutic targets in covid-19 patients LIII Reunião da Sociedade Portuguesa de Farmacologia (SPF 2023)
Sociedade Portuguesa de Farmacologia (Coimbra, Portugal)
2023/02/01 Oxidative stress association with covid-19 severity and mortality: focus on urinary isoprostanes LIII Reunião da Sociedade Portuguesa de Farmacologia (SPF 2023)
Sociedade Portuguesa de Farmacologia (Coimbra, Portugal)
2022/06 Resolution of inflammation versus proinflammatory status in human acute heart failure and cardiogenic shock 15th World Congress on Inflammation
Italian Society of Pharmacology (Rome, Itália)
2022/02/11 ACE2/ACE balance in COVID-19 patients with different disease severity. LII Reunião da Sociedade Portuguesa de Farmacologia (SPF 2022)
Sociedade Portuguesa de Farmacologia (Porto, Portugal)
2022/02/09 Impact of previous ß-blocker treatmenton inflammatory status of acute heart failure and cardiogenic shock patients. LII Reunião da Sociedade Portuguesa de Farmacologia (SPF 2022)
Sociedade Portuguesa de Farmacologia (Porto, Portugal)
2022/02/09 Arachidonic acid derived proresolving or proinflammatory mediators and lipoxin receptor expression in human acute heart failure and cardiogenic shock LII Reunião da Sociedade Portuguesa de Farmacologia (SPF 2022)
Sociedade Portuguesa de Farmacologia (Porto, Portugal)
2022/02/09 Inflammatory cytokine response in moderate and severe COVID-19 patients and its relationship to prognosis. LII Reunião da Sociedade Portuguesa de Farmacologia (SPF 2022)
Sociedade Portuguesa de Farmacologia (Porto, Portugal)
2021/12/08 Evaluation of serum and urinary lipoxin profiles and FPR2/ALX receptor expression in human acute heart failure, cardiogenic shock and septic shock. 8th European Virtual Congress of Pharmacology (EPHAR 2021)
EPHAR (República Checa)
2021/12/08 Inflammatory and resolution of inflammation responses in critically ill patients with cardiogenic shock, septic shock and severe COVID-19. 8th European Virtual Congress of Pharmacology (EPHAR 2021)
EPHAR (República Checa)
2021/12/08 Comparison of endothelial activation profiles in critically ill patients with cardiogenic shock, septic shock and severe COVID-19. 8th European Virtual Congress of Pharmacology (EPHAR 2021)
EPHAR (República Checa)
2021/02/18 Endothelial cell activation and proinflammatory status decrease during hospitalization in septic shock but not in cardiogenic shock. LI Reunião da Sociedade Portuguesa de Farmacologia
Universidade de Lisboa Faculdade de Farmácia (Portugal)
2021/02/18 Urinary biomarkers of oxidative stress, inflammation and vascular dysfunction in septic shock patients and their relationship with organ dysfunction and prognosis. LI Reunião da Sociedade Portuguesa de Farmacologia
Universidade de Lisboa Faculdade de Farmácia (Portugal)
2021/02/17 Resolution of inflammation in human acute heart failure and cardiogenic shock: role of resolvin D1 and E1. LI Reunião da Sociedade Portuguesa de Farmacologia
Universidade de Lisboa Faculdade de Farmácia (Portugal)
2020/09 Proinflammatory cytokines and endothelial cell activation in human acute heart failure and cardiogenic shock. ESCI Virtual - COVID Edition 2020
2020/09 Lipoxin profiles in human acute heart failure and cardiogenic shock and their modulation by aspirin or statin therapy. ESCI Virtual - COVID Edition 2020
2020/02 Comparison of the inflammatory profile in patients with cardiogenic shock or septic shock L Reunião da Sociedade Portuguesa de Farmacologia
Sociedade Portuguesa de Farmacologia (Coimbra, Portugal)
2020/02 Serum and urinary lipoxins profiles in patients with acute heart failure and cardiogenic shock L Reunião da Sociedade Portuguesa de Farmacologia
Sociedade Portuguesa de Farmacologia (Coimbra, Portugal)

Organização de evento

Event name
Type of event (Role) 		Institution / Organization
2025/02/05 - 2025/02/07 Member of the Organising Committee of the 55ª Reunião da Sociedade Portuguesa de Farmacologia, 2025, FMUP, Porto, Portugal (2025/02/05 - 2025/02/07)
Congresso (Membro da Comissão Organizadora)
 Universidade do Porto Faculdade de Medicina, Portugal

Participação em evento

Activity description
Type of event 		Event name
Institution / Organization
2024/07/03 - 2024/07/05 Encontro Ciência 2024 – Encontro com a Ciência e a Tecnologia em Portugal
Congresso
 Encontro Ciência 2024 – Encontro com a Ciência e a Tecnologia em Portugal
2024/06/26 - 2024/06/28 9th European Workshop on Lipid Mediators
Oficina (workshop)
 9th European Workshop on Lipid Mediators
The University of Edinburgh Medical School, Reino Unido
2024/04/17 - 2024/04/17 12th Workshop in Lipidomics 2024 – Online Event “Marine Lipidomics”
Oficina (workshop)
 12th Workshop in Lipidomics 2024 – Online Event “Marine Lipidomics”
Universidade de Aveiro Centro de Espectrometria de Massa, Portugal
2024/04/03 - 2024/04/03 12th Workshop in Lipidomics 2024 – Online Event “Food Lipidomics”
Oficina (workshop)
 12th Workshop in Lipidomics 2024 – Online Event “Food Lipidomics”
Universidade de Aveiro Centro de Espectrometria de Massa, Portugal
2024/03/27 - 2024/03/27 12th Workshop in Lipidomics 2024 – Online Event “Lipidomics in Health & Disease”
Oficina (workshop)
 12th Workshop in Lipidomics 2024 – Online Event “Lipidomics in Health & Disease”
Universidade de Aveiro Centro de Espectrometria de Massa, Portugal
2024/02/07 - 2024/02/09 54th Meeting of the Portuguese Society of Pharmacology
Encontro
 54th Meeting of the Portuguese Society of Pharmacology
Universidade Nova de Lisboa Medical School, Portugal
2023/09/27 - 2023/09/27 Seminar “Renin-Angiotensin-Aldosterone System in Health and Disease - New insights into a classic system”
Seminário
 Seminar “Renin-Angiotensin-Aldosterone System in Health and Disease - New insights into a classic system”
2023/07/02 - 2023/07/07 19th World Congress of Basic & Clinical Pharmacology 2023
Congresso
 19th World Congress of Basic & Clinical Pharmacology 2023 (WCP2023)
2023/04 - 2023/04 Science communication - Presentation entitled: ""Medical doctor scientists @FMUP: the experience of medical students in the research of new therapeutic targets in cardiovascular and infectious diseases"
Exposição
 20ª Mostra da Universidade do Porto
Universidade do Porto, Portugal
2023/02/01 - 2023/02/03 53rd Meeting of the Portuguese Society of Pharmacology
Encontro
 53rd Meeting of the Portuguese Society of Pharmacology
2022/02/09 - 2022/02/11 52nd Meeting of the Portuguese Society of Pharmacology
Encontro
 52nd Meeting of the Portuguese Society of Pharmacology
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2021/12/06 - 2021/12/08 8th European Virtual Congress of Pharmacology (EPHAR 2021)
Congresso
 8th European Virtual Congress of Pharmacology (EPHAR 2021)
2021/09/22 - 2021/09/22 Workshop Y-GEDII: How to get my research published
Encontro
 GEDII Annual Meeting
2021/02/17 - 2021/02/19 51st Meeting of the Portuguese Society of Pharmacology – Virtual Edition
Encontro
 51st Meeting of the Portuguese Society of Pharmacology – Virtual Edition
Universidade de Lisboa Faculdade de Farmácia, Portugal
2020/09/20 - 2020/09/30 European Society for Clinical Investigation Virtual Meeting 2020 – Covid19 Edition
Encontro
 European Society for Clinical Investigation Virtual Meeting 2020 – Covid19 Edition
2020/02/05 - 2020/02/07 50th Meeting of the Portuguese Society of Pharmacology
Encontro
 50th Meeting of the Portuguese Society of Pharmacology
Universidade de Coimbra Faculdade de Farmácia, Portugal
2019/10/24 - 2019/10/25 Curso de Estatística Aplicada à Investigação Básica
Oficina (workshop)
Universidade do Porto Faculdade de Medicina, Portugal
2019/06/16 - 2019/06/16 Scientific Writing Workshop “General Principles for Obtaining a Scientific Publication”
Oficina (workshop)
ReadytoPub, Portugal
2019/05/06 - 2019/05/06 1ª Reunião do Programa Doutoral em Farmacologia e Toxicologia Experimental e Clínica (PDFTEC)
Congresso
Universidade do Porto Faculdade de Medicina, Portugal
2018/07/27 - 2018/07/29 Experimental Models in Physiology
Congresso
University of Exeter, Reino Unido

Curso / Disciplina lecionado

Academic session Degree Subject (Type) Institution / Organization
2024/09 - Current Pharmacology I Medicina (Mestrado integrado) Universidade do Porto Faculdade de Medicina, Portugal

Membro de associação

Society Organization name Role
2020 - Current Sociedade Portuguesa de Farmacologia Student member
2019 - Current Ordem dos Farmacêuticos

Tutoria

Topic Student name
2021 - 2022 Evaluation of urinary 11-dehydrothromboxane B2 as a biomarker of severity and putative therapeutic target in human acute heart failure Ana Isabel Sousa Oliveira
2021 - 2022 Evolution of endocan and other endothelial dysfunction markers in COVID-19 patients with different stages of disease severity. David André Rosário Alves
Distinctions

Prémio

2024 Ambiotis Poster Award
Ambiotis SAS, França
2023 Molecular Biology & Physiology Parallel Oral Session First Prize – Prémio Fundação Professor Ernesto Morais
2020 ESCI Short Presentation Award
European Society of Clinical Investigation, Países Baixos